SAB Biotherapeutics Progressing on Therapeutic for COVID-19

Click Here To View


Executive Team

Eddie J. Sullivan, PhD
Co-Founder, President & CEO

Eddie Hamilton, DVM
Co-Founder, Executive Chairman BOD

Charles Randall, Jr.
Chief Strategy Officer & Executive VP

Tim Cunningham, CPA
Chief Financial Officer

Rick Finnegan
Chief Business Officer
Executive VP of Program Management

Melissa Ullerich 
Chief Corporate Communications Officer
Executive VP

Christoph Bausch, PhD
Chief Science Officer

Tom Luke, MD
Chief Medical Officer

Jerry Pommer, MSc, PAS, DACAWS
Chief Compliance Officer

Hua Wu, PhD
Senior VP, Vaccinology and Antibody Development


Executive Directors

Todd Stahl, MS
Animal Management

Kristi Egland, PhD
Molecular Genetics and Immunology

Board of Directors

Eddie Hamilton, DVM
Co-Founder & Executive Chairman

David Link
Vice Chairman
Former Executive Vice President
Sanford Health

Eddie J. Sullivan, PhD
Co-Founder, President, CEO
SAB Biotherapeutics

Christine Hamilton
Co-Founder, SAB Biotherapeutics
Managing Partner, Christiansen Land & Cattle
Co-Owner BioDak, LLC

Bill Polvino, MD
Bridge Medicines

Mervyn Turner, PhD
Former Head of Strategy

Mani Mohindru, PhD
Former CEO
Cerexis, Inc.

Scientific Advisory Board

Jim Robl, PhD
Retired Biotechnology Executive & Professor

Scott A. Lesley, Ph.D.
Vice President, Discovery Biologics
Merck Research Laboratories

Arturo Casadevall, MD, PhD
Bloomberg Distinguished Professor of Molecular Microbiology & Immunology and Infectious Diseases
Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine

Michael Haller, MD, MS–CI
Chief, Program Director, Pediatric Endocrinology and Professor
University of Florida Medical Center

Stephen E. Gitelman, MD
Professor of Clinical Pediatrics
KAK Distinguished Professor in Pediatric Diabetes and Clinical Research
University of California-San Francisco

Contact Us

2301 E 60th St N
Sioux Falls, SD 57104

245 First Street, Suite 1836
Cambridge, MA 02142